Trial Cancellations And Delays Persist For CROs Amid Biotech Slowdown

 
• By Vibha Sharma
  
The path is interrupted by uncertainty. Uncertainty, threat and danger. Resolve the problem before continuing your journey. Bring a gap.
Ongoing pharma uncertainty is fueling trial setbacks for CROs (Shutterstock)

More from Clinical Trials

More from North America